We tested our hypothesis that the activation of PAR1 in cytotoxic T cells is associated with the incidence of MACE in our third cohort of 80 AF patients (independent of the first cohort) that were already on stable anti-thrombotic therapy after their first AF diagnosis. Here, F2R is linked to atrial fibrillation.